These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 6692407)

  • 1. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
    Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyotypic characterization of urinary bladder transitional cell carcinomas.
    Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
    Genes Chromosomes Cancer; 2000 Nov; 29(3):256-65. PubMed ID: 10992300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic features of human neuroblastomas and cell lines.
    Brodeur GM; Green AA; Hayes FA; Williams KJ; Williams DL; Tsiatis AA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4678-86. PubMed ID: 6171342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
    Yoshida MA; Ohyashiki K; Ochi H; Gibas Z; Pontes JE; Prout GR; Huben R; Sandberg AA
    Cancer Res; 1986 Apr; 46(4 Pt 2):2139-47. PubMed ID: 3948185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding.
    Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
    Br J Cancer; 1999 Sep; 81(1):6-12. PubMed ID: 10487605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
    Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
    Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor.
    Kondo K; Chilcote RR; Maurer HS; Rowley JD
    Cancer Res; 1984 Nov; 44(11):5376-81. PubMed ID: 6091875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.
    Falor WH; Ward RM
    Acta Cytol; 1976; 20(3):272-5. PubMed ID: 1064279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
    Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
    Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
    Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
    Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal analysis of bladder cancer. III. Nonrandom alterations.
    Smeets W; Pauwels R; Laarakkers L; Debruyne F; Geraedts J
    Cancer Genet Cytogenet; 1987 Nov; 29(1):29-41. PubMed ID: 3311350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe.
    Poddighe PJ; Ramaekers FC; Smeets AW; Vooijs GP; Hopman AH
    Cancer Res; 1992 Sep; 52(18):4929-34. PubMed ID: 1516049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
    Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
    Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
    Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
    Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
    Panani AD; Ferti AD; Raptis SA; Roussos C
    Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromosomal analysis of primary superficial tumors of the bladder].
    Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
    J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.